|
End-of-day quote
Korea S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 14,890.00 KRW | -4.12% |
|
-10.68% | -74.06% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-22 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
| Market Cap | 224B 168M 150M 138M 125M 234M 15.92B 238M 1.65B 661M 8.38B 629M 616M 26.42B | P/E 2024 * |
-
| P/E 2025 | -77.1x |
|---|---|---|---|---|---|
| Enterprise Value | 203B 152M 136M 125M 114M 212M 14.46B 216M 1.5B 600M 7.61B 571M 559M 23.98B | EV / Sales 2024 * |
-
| EV / Sales 2025 | 365,559,272x |
| Free-Float |
79.07% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.12% | ||
| 1 week | -10.68% | ||
| Current month | -14.13% | ||
| 1 month | -14.13% | ||
| 3 months | +2.83% | ||
| 6 months | -59.92% | ||
| Current year | -74.06% |
| 1 week | 14,510 |  | 17,000 |
| 1 month | 13,200 | | 18,970 |
| Current year | 13,050 | | 63,500 |
| 1 year | 13,050 | | 74,900 |
| 3 years | 13,050 | | 74,900 |
| 5 years | 13,050 | | 74,900 |
| 10 years | 13,050 | | 74,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tae-Kyo Park
CEO | Chief Executive Officer | 66 | 01/04/2015 |
Young-Seok Seo
DFI | Director of Finance/CFO | 69 | 01/06/2019 |
Yo-Seop Yu
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Tae-Kyo Park
BRD | Director/Board Member | 66 | 01/04/2015 |
Yo-Seop Yu
BRD | Director/Board Member | 58 | 01/04/2021 |
Gyeong-Se Min
BRD | Director/Board Member | 65 | 01/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/07/25 | Buy | Founder | 10,000 | 0.0674% | ||
| 15/07/25 | Buy | Founder | 26,000 | 0.1751% | ||
| 28/05/25 | Free | 40,400 | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.12% | -10.68% | -75.14% | - | 168M | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | -0.11% | +6.03% | +35.56% | +206.32% | 39.45B | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.45% | +186.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.91K 2.18 1.95 1.79 1.63 3.04 206.81 3.1 21.4 8.59 108.79 8.17 8 343.07 | 2.3K 1.72 1.54 1.42 1.29 2.41 163.67 2.45 16.93 6.8 86.1 6.47 6.33 271.52 |
| Net income | -9.91B -7.43M -6.66M -6.12M -5.55M -10.37M -706M -10.56M -73.01M -29.31M -371M -27.89M -27.3M -1.17B | -10.6B -7.95M -7.12M -6.55M -5.93M -11.09M -755M -11.3M -78.1M -31.35M -397M -29.84M -29.2M -1.25B |
| Net Debt | -2.15B -1.61M -1.44M -1.33M -1.2M -2.24M -153M -2.29M -15.81M -6.35M -80.36M -6.04M -5.91M -253M | -20.59B -15.43M -13.82M -12.72M -11.52M -21.54M -1.47B -21.94M -152M -60.87M -771M -57.92M -56.69M -2.43B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ₩14,890.00 | -4.12% | 18,519 |
| 29/10/26 | ₩15,530.00 | -4.72% | 21,804 |
| 28/10/26 | ₩16,300.00 | +2.00% | 21,661 |
| 27/10/26 | ₩15,980.00 | -0.75% | 22,757 |
| 26/10/26 | ₩16,100.00 | -3.42% | 12,099 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A287840 Stock
Select your edition
All financial news and data tailored to specific country editions
